Through investigation and discovery, Brigham and Women’s Hospital (BWH) is an international leader in basic, clinical and translational research on human diseases, with more than 1,300 physician-investigators and renowned biomedical scientists and faculty and 1,700 physicians supported by nearly $650 million in research funding. BWH is a teaching hospital affiliated with Harvard Medical School.
In 1998, the BWH Department of Medicine created the Division of Pharmacoepidemiology and Pharmacoeconomics to facilitate a wide range of activities related to the use and outcomes of medications, addressed from a variety of interdisciplinary perspectives. Its mission is to bring together the various specialties of medicine, epidemiology, biostatistics, health services research, and the social sciences to evaluate the effectiveness of existing and new prescription drugs in relation to their risks and costs; to study how medications are used by physicians and patients; and to develop methods to optimize prescription drug use.
